Polysaccharides-based nanoparticles as drug delivery systems.
By Zong-hua Liu, Y. Jiao, Yifei Wang, Changren Zhou, Zi-yong Zhang. Advanced Drug Delivery Reviews, 2008
1,614 citations recorded by the source corpus.
Subfields: Molecular Medicine, Pharmaceutical Science, Surfaces, Coatings and Films
View Paper: https://www.semanticscholar.org/paper/0d60c069ca3dcc9c37089ed49b43f1485baba15b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Medicine
In Pharmaceutical Science
In Surfaces, Coatings and Films
Citations in the corpus
- Advanced Materials and Processing for Drug Delivery: The Past and the Future (2012, background): “The use of polysaccharides [70] such as heparin, chondroitin sulfate, and chitosan [70, 71] as carriers, and coupled with the use of antibody [72, 73] and transferrin [73, 74] as targeting motif has all brought significant clinical benefits.”
- Targeted delivery of low molecular drugs using chitosan and its derivatives. (2010, background): “tion because of their outstandingphysical and biological properties [11].”
- Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, background): “Such systems were proven to be more efficient than synthetic polymers in terms of better drug loading capacity, biocompatibility, and generate less opsonization by the reticuloendothelial system (Liu et al., 2008).”